LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

Search

Pfizer

Cerrado

SectorSalud

24.87 1.14

Resumen

Variación precio

24h

Actual

Mínimo

24.56

Máximo

25.12

Métricas clave

By Trading Economics

Ingresos

-45M

2.9B

Ventas

938M

15B

P/B

Media del Sector

13.048

77.256

BPA

0.51

Rentabilidad por dividendo

6.9

Margen de beneficio

19.982

Empleados

81,000

EBITDA

266M

5.3B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+18.16% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

6.90%

2.33%

Fecha Próximo Dividendo

1 dic 2025

Próxima Fecha de Ex Dividendo

7 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

6.4B

140B

Apertura anterior

23.73

Cierre anterior

24.87

Noticias sobre sentimiento de mercado

By Acuity

44%

56%

156 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Pfizer Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

6 nov 2025, 20:02 UTC

Adquisiciones, fusiones, absorciones

Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. -- Barrons.com

6 nov 2025, 16:16 UTC

Ganancias

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

6 nov 2025, 12:29 UTC

Ganancias

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 nov 2025, 12:15 UTC

Ganancias

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 nov 2025, 00:24 UTC

Adquisiciones, fusiones, absorciones

Metsera: Pfizer Has Reiterated It Will Continue to Litigate >MTSR

6 nov 2025, 00:24 UTC

Adquisiciones, fusiones, absorciones

Metsera: Board of Directors Will Continue to Stand Firm on Behalf of Shareholders, Patients >MTSR

6 nov 2025, 00:24 UTC

Adquisiciones, fusiones, absorciones

Metsera: Gratified by Court Decision to Deny Pfizer's Request for Temporary Restraining Order to Block Board From Acting in Shareholders' Best Interests >MTSR

6 nov 2025, 00:22 UTC

Adquisiciones, fusiones, absorciones

Metsera Issues Statement in Response to Pfizer Litigation Ruling

5 nov 2025, 22:44 UTC

Adquisiciones, fusiones, absorciones

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 nov 2025, 22:12 UTC

Adquisiciones, fusiones, absorciones

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 nov 2025, 22:11 UTC

Adquisiciones, fusiones, absorciones

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 nov 2025, 22:11 UTC

Adquisiciones, fusiones, absorciones

Pfizer Responds to Delaware Chancery Court Ruling

5 nov 2025, 21:52 UTC

Adquisiciones, fusiones, absorciones

Pfizer Plans to Deliver Bid Wednesday, Sources Say -- WSJ

5 nov 2025, 21:52 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Recently Offered Up to $10B for Metsera -- WSJ

5 nov 2025, 21:52 UTC

Adquisiciones, fusiones, absorciones

Pfizer Preps Improved Offer in Metsera Bidding War -- WSJ

5 nov 2025, 21:52 UTC

Adquisiciones, fusiones, absorciones

Pfizer Preparing New Bid for Metsera, Sources Say -- WSJ

5 nov 2025, 15:43 UTC

Ganancias

Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. -- Barrons.com

5 nov 2025, 13:06 UTC

Ganancias

Novo Nordisk Stock Falls After Earnings. It Cut Guidance on These Fears. -- Barrons.com

5 nov 2025, 12:30 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Stock Rises After Earnings. It Cut Guidance on These Fears. -- Barrons.com

5 nov 2025, 10:00 UTC

Ganancias

Novo Nordisk Stock Up After Earnings. Guidance Cut on These Weight-Loss Drug Fears. -- Barrons.com

4 nov 2025, 22:10 UTC

Adquisiciones, fusiones, absorciones

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4 nov 2025, 19:39 UTC

Adquisiciones, fusiones, absorciones

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- Update

4 nov 2025, 18:35 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera -- Barrons.com

4 nov 2025, 18:11 UTC

Ganancias

Pfizer 3Q Profit Falls Amid Lower Covid-19 Drug Demand -- 2nd Update

4 nov 2025, 17:59 UTC

Ganancias

Pfizer Stock Slips. Under the Surface, Earnings Weren't Great. -- Barrons.com

4 nov 2025, 17:26 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera -- Barrons.com

4 nov 2025, 16:01 UTC

Adquisiciones, fusiones, absorciones

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- WSJ

4 nov 2025, 15:17 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk and Pfizer Sweeten Their Offers for Weight-Loss Drug Startup Metsera -- WSJ

4 nov 2025, 14:58 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Sweetens Offer for Metsera -- WSJ

4 nov 2025, 14:37 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk: Proposal Is Subject to Terms of Pfizer's Merger Pact With Metsera

Comparación entre iguales

Cambio de precio

Pfizer Esperado

Precio Objetivo

By TipRanks

18.16% repunte

Estimación a 12 meses

Media 29.08 USD  18.16%

Máximo 34 USD

Mínimo 24 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

14 ratings

3

Comprar

10

Mantener

1

Vender

Puntuación técnica

By Trading Central

22.855 / 23.85Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

156 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat